Literature DB >> 3530499

Developmental progression of myosin gene expression in cultured muscle cells.

L Silberstein, S G Webster, M Travis, H M Blau.   

Abstract

Myosin heavy chains are encoded by distinct members of a multigene family at different stages of muscle development. Study of the underlying regulatory mechanisms has been hindered because transitions in myosin expression have not been readily attained in tissue culture. Here we show a transition from early (fetal) to late (perinatal/adult) myosins defined by two monoclonal antibodies, F1.652 and N3.36, in the myotubes of mouse C2C12 cells. On day 1 of differentiation, essentially all myosin was early myosin. By day 8, early myosin dropped to 25% of its day 1 value and was replaced by late myosin. The transition occurred without neural contact, connective tissue components, or complex substrates, suggesting that its regulation may be intrinsic to the muscle cell. Our results demonstrate that a developmental progression in myosin gene expression, which occurs rapidly, with high frequency, and under relatively simple conditions, is now amenable to molecular analysis in cultured muscle cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530499     DOI: 10.1016/0092-8674(86)90707-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  69 in total

1.  Characterisation of human soft palate muscles with respect to fibre types, myosins and capillary supply.

Authors:  P S Stål; R Lindman
Journal:  J Anat       Date:  2000-08       Impact factor: 2.610

2.  Remarkable heterogeneity in myosin heavy-chain composition of the human young masseter compared with young biceps brachii.

Authors:  Catharina Osterlund; Mona Lindström; Lars-Eric Thornell; Per-Olof Eriksson
Journal:  Histochem Cell Biol       Date:  2012-07-10       Impact factor: 4.304

3.  Ferritin overexpression for noninvasive magnetic resonance imaging-based tracking of stem cells transplanted into the heart.

Authors:  Anna V Naumova; Hans Reinecke; Vasily Yarnykh; Jennifer Deem; Chun Yuan; Charles E Murry
Journal:  Mol Imaging       Date:  2010-08       Impact factor: 4.488

4.  Magnetic Resonance Imaging Tracking of Graft Survival in the Infarcted Heart: Iron Oxide Particles Versus Ferritin Overexpression Approach.

Authors:  Anna V Naumova; Niranjan Balu; Vasily L Yarnykh; Hans Reinecke; Charles E Murry; Chun Yuan
Journal:  J Cardiovasc Pharmacol Ther       Date:  2014-03-30       Impact factor: 2.457

5.  Perinuclear localization of slow troponin C m RNA in muscle cells is controlled by a cis-element located at its 3' untranslated region.

Authors:  Kishore K Reddy; Ferry M Oitomen; Gopal P Patel; Jnanankur Bag
Journal:  RNA       Date:  2005-03       Impact factor: 4.942

6.  Four sarcomeric myosin heavy chain genes are expressed by human fetal skeletal muscle cells differentiating in culture.

Authors:  R Feghali; I Karsch-Mizrachi; L A Leinwand; D S Kohtz
Journal:  Gene Expr       Date:  1992

7.  Localization of epitopes and functional effects of two novel monoclonal antibodies against skeletal muscle myosin.

Authors:  M Dan-Goor; L Silberstein; M Kessel; A Muhlrad
Journal:  J Muscle Res Cell Motil       Date:  1990-06       Impact factor: 2.698

8.  Myosin heavy chain mRNA isoforms are expressed in two distinct cohorts during C2C12 myogenesis.

Authors:  David M Brown; Tim Parr; John M Brameld
Journal:  J Muscle Res Cell Motil       Date:  2011-10-20       Impact factor: 2.698

9.  Expression of M-cadherin, a member of the cadherin multigene family, correlates with differentiation of skeletal muscle cells.

Authors:  M Donalies; M Cramer; M Ringwald; A Starzinski-Powitz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

10.  Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro.

Authors:  H Ito; S C Miller; M E Billingham; H Akimoto; S V Torti; R Wade; R Gahlmann; G Lyons; L Kedes; F M Torti
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.